Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Angioimmunoblastic T-cell lymphoma
ADR ID BADD_A00235
ADR Hierarchy
01      Blood and lymphatic system disorders
01.11      Lymphomas non-Hodgkin's T-cell
01.11.05      Angioimmunoblastic T-cell lymphomas
01.11.05.001      Angioimmunoblastic T-cell lymphoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.17      Lymphomas non-Hodgkin's T-cell
16.17.05      Angioimmunoblastic T-cell lymphomas
16.17.05.001      Angioimmunoblastic T-cell lymphoma
Description Not Available
MedDRA Code 10002449
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Angioimmunoblastic T-cell lymphoma | Angioimmunoblastic T-cell lymphoma NOS | Angiomimmunoblastic (AILD, LgX (Kiel Classification) | Diffuse large cell lymphoma (Angioimmunoblastic T-cell lymphoma) (Working Formulation) | Diffuse mixed small and large cell lymphoma (Angioimmunoblastic T-cell lymphoma) | IBL-like T-cell lymphoma (Lukes-Collins Classification) | Large cell immunoblastic lymphoma (Angioimmunoblastic T-cell lymphoma) (Working Formulation)
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00076Allopurinol0.000034%
BADD_D00914Fludarabine0.000533%
BADD_D01253Lenalidomide0.000302%
BADD_D01567Nilotinib0.000533%
The 1th Page    1    Total 1 Pages